In vivo Safety & Identity Testing of rBCG Vaccine

Project Description

MULTIPLE TESTING & SAMPLES

We are seeking a GMP/GLP qualified laboratory capable of performing in vivo safety and identity testing on finished recombinant BCG vaccine lots, specifically:

In vivo general safety testing in mice and guinea pigs, following legacy 21 CFR 610.11 methodology (withdrawn but still accepted as industry best practice) and aligned with WHO TRS 978, Annex 3 (2013) for BCG vaccines.

These tests should evaluate clinical signs, weight change, and mortality over a 7-day observation period.

Freedom from virulent mycobacteria test in guinea pigs, which involves high-dose subcutaneous inoculation followed by 42 days of observation, histopathological examination, and PCR testing for virulence-associated markers (e.g., ESAT-6). This assay must confirm the absence of reversion to a virulent form and rule out contamination with M. tuberculosis.

All testing must be performed in full compliance with GLP (21 CFR Part 58) and demonstrate alignment with current standards for biological product lot release as outlined in 21 CFR and WHO GMP.

We require detailed reporting, including protocol approval by an IACUC or equivalent ethical review board, raw data, histological reports, PCR results, and a final signed report certifying the results.

The service provider must have experience with biologicals, preferably with BCG or mycobacterial vaccines, and be authorized to issue reports suitable for submission to regulatory authorities (FDA, EMA, WHO PQ).

We would appreciate a technical and regulatory confirmation, along with estimated timelines, documentation requirements, and relevant certifications.

Project Information

Number:25-01047

Industry:Pharmaceuticals

This request is open and accepting quotes! Register or Log In to unlock more information or respond to this request.

Other pharmaceuticals laboratory services.

Other Pharmaceuticals testing, analysis, scientific research and development, inspection, certification, engineering, failure investigation, and product development needs include :

Drug Discovery Testing

Drug Development Testing

Non-Clinical Study Testing

Preclinical Study Testing

Clinical Trials Testing

Pharmacokinetics (PK) Testing

Pharmacodynamics (PD) Testing

ADME Testing

Sterility Testing

Pyrogens Testing

Endotoxins Testing

Raw Material Testing

Finished Product Quality Control Release Testing

Real-Time Stability Testing

Accelerated Stability Testing

Method Development Testing

Method Validation Testing

Drug Release/Dissolution Testing

Extractable Testing

Leachable Testing

Elemental Impurities Testing

Packaging Testing

Child-Resistant Packaging Testing

Container Closure Integrity Testing (CCIT) Testing

High Throughput Screening Testing

Reverse Pharmacology Testing

Excipients Testing

Active Pharmaceutical Ingredient API Testing

Toxicology Testing

Toxicity Testing

Microbiology Testing

Strength Testing

Quality Testing

Purity Testing

Consistency Testing

Acid Insolubles Testing

Acid Solubles Testing

Alkali Solubles Testing

Alkalinity Testing

Appearance Testing

Boiling Point Testing

Congealing Temperature Testing

Flash Point Testing

Melting Point Testing

Freezing Point Testing

Hardness Testing

Heat of Combustion Testing

Preservatives Testing

Loss on Drying (under Vacuum) Testing

Loss on Ignition Testing

Melting Point Testing

Mineral Analysis Testing

Non-aqueous Titration Testing

Normality Testing

Organic Acids Testing

Organic Extractives Testing

Oxidizing Substances Testing

Peroxide Value Testing

Pour Point Testing

Reactivity Testing

Reactivity to Water Testing

Reducing Substances Testing

Refractive Index Testing

Residue on Evaporation Testing

Residue on Ignition Testing

Saponification Value Testing

Sieve Analysis Testing

Silver Reducing Substances Testing

Silicon Testing

Sulfur Testing

Sodium Testing

Specific Gravity Testing

Specific Rotation Testing

Sugars Testing

Sulfur Compounds Testing

Surfactants Testing

Talc Testing

Titration Curve Testing

Total Halides Testing

Total Reducing Compounds Testing

Unburned Carbon Testing

Uncarbonized Constituents Testing

Unsaponifiable Matter Testing

UV Absorption Testing

Volatile Matter Testing

Volatile Suspended Solids Testing

Weight Variation Testing

Cytotoxicity Testing

Elution Testing

Agar Diffusion Testing

Bioburden Testing

Antimicrobial Effectiveness Testing

Particulates Testing

Total Combined Mold & Yeast (TYMC) Testing

Total Aerobic Microbial Count (TAMC) Testing

Testing

Learn more about pharmaceuticals testing and research

In vivo Safety & Identity Testing of rBCG Vaccine

Project Description

Project Information

Test Request: 25-01044

Test Request: 25-01043

Test Request: 25-01032